SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results
16 references·0 citing·31 second hop
Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results (2021)Estimating the Cost of Industry Investmen…Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment (2021)Challenges in ensuring global…Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Estimated Research and Develo…Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval (2017)Research and Development Spen…The High Cost of Prescription Drugs in the United States (2016)The High Cost of Prescription…Key cost drivers of pharmaceutical clinical trials in the United States (2016)Key cost drivers of pharmaceu…Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Innovation in the pharmaceuti…The $2.6 Billion Pill — Methodologic and Policy Considerations (2015)The $2.6 Billion Pill — Metho…Clinical development success rates for investigational drugs (2014)Clinical development success …The cost of drug development: A systematic review (2011)The cost of drug development:…Demythologizing the high costs of pharmaceutical research (2011)Demythologizing the high cost…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Spending on new drug development1 (2009)Spending on new drug developm…Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Estimating The Cost Of New Dr…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Cost of innovation in the pharmaceutical industry (1991)Cost of innovation in the pha…Economic Welfare and the Allocation of Resources for Invention (1962)Economic Welfare and the Allo…Can the pharmaceutical industry reduce attrition rates? (2004)Changing R&D models in research-based pharmaceutical companies (2016)A Comprehensive Map of FDA-Approved Pharmaceutical Products (2018)Conditional logit analysis of qualitative choice behavior (1972)Qualitative Response Models: A Survey (1994)Sources and Financial Consequences of Radical Innovation: Insights from Pharmaceuticals (2003)Against Intellectual Monopoly (2008)Essential medicines for universal health coverage (2016)Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)The productivity crisis in pharmaceutical R&D (2011)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Cost-Effectiveness in Health and Medicine (1996)Diagnosing the decline in pharmaceutical R&D efficiency (2012)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)The high price of anticancer drugs: origins, implications, barriers, solutions (2017)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment (2021)Methods for the Economic Evaluation of Health Care Programmes (2005)On the Opportunities and Risks of Foundation Models (2021)Costs of Drug Development and Research and Development Intensity in the US, 2000-2018 (2024)Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012 (2014)Vaccine hesitancy: Definition, scope and determinants (2015)A global survey of potential acceptance of a COVID-19 vaccine (2020)COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries (2021)COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries (2021)Understanding COVID-19 vaccine hesitancy (2021)Crime and Punishment: An Economic Approach (1968)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)The Promise of Enterpreneurship as a Field of Research (2000)
this work references cited by second hop

References

  • 1962Economic Welfare and the Allocation of Resources for Invention8,931 cited
  • 2003The price of innovation: new estimates of drug development costs4,264 cited
  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,562 cited
  • 2016Innovation in the pharmaceutical industry: New estimates of R&D costs3,352 cited
  • 2014Clinical development success rates for investigational drugs2,531 cited
  • 2020Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-20181,528 cited
  • 2021Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment1,291 cited
  • 2006Estimating The Cost Of New Drug Development: Is It Really $802 Million?906 cited
  • 1991Cost of innovation in the pharmaceutical industry763 cited
  • 2016The High Cost of Prescription Drugs in the United States591 cited
  • 2011The cost of drug development: A systematic review510 cited
  • 2017Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval503 cited
  • 2016Key cost drivers of pharmaceutical clinical trials in the United States401 cited
  • 2015The $2.6 Billion Pill — Methodologic and Policy Considerations319 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2009
Spending on new drug development1
277 cited
  • 2011Demythologizing the high costs of pharmaceutical research213 cited
  • Cited by

    No citing works inside the corpus for this window.